Article ID Journal Published Year Pages File Type
10764468 Biochemical and Biophysical Research Communications 2011 6 Pages PDF
Abstract
► MED25 and PTOV1 compete for CBP binding through the common PTOV domain. ► MED25 increases, whereas PTOV1 decreases CBP binding to RA-responsive chromatin. ► MED25 elevates, while PTOV1 suppresses RA-induced transcriptional activity of RAR. ► MED25 and PTOV1 are determinants of RA sensitivity critical for cancer therapy.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Authors
, , , ,